Treatment of cutaneous leishmaniasis with radiofrequency microneedling
Keywords:cutaneous leishmaniasis, radiofrequency microneedling, treatment
AbstractObjectives: To assess the efficacy of radiofrequency microneedling in the treatment of cutaneous leishmaniasis particularly in preventing or at least minimizing the potential scarring Patients and methods: This is an open interventional therapeutic trial and was conducted in a private dermatology clinic in Missan province, Iraq between the period from January 2019 to December 2021. Sixty patients diagnosed with cutaneous leishmaniasis participated in this study. A detailed history and examination were done on every patient. We used a radiofrequency microneedling machine (NBW-FR200)© to treat lesions of CL. The depth of microneedles used in this study ranged from 2 to 3 mm according to the area treated and the degree of lesional induration. The interval between sessions was one week. The status of each lesion was documented every week including size and degree of erythema and of induration. Results: Only 54 patients completed the trial period, their age was 15.4 ± 13.3 years. The male to female ratio was 0.8:1. The duration of lesions ranged from 25 days to 5 months. A solitary lesion was encountered in 23 patients, the total number of treated lesions was 125 and the upper limbs were the most commonly affected area. The size of lesions ranged from 0.5 to 6 cm in diameter with a mean ± SD of 2.46 ± 1.17 cm. and ulcerative type was seen in 75 (60%) lesions. Two to six therapeutic sessions were done for all patients and the cure rate was 88.8%. Most patients encounter minor side effects after therapeutic sessions. All treated patients were followed up every month for 6 months. No recurrence has been detected in all cases. Conclusion: Radiofrequency microneedling has a high cure rate for cutaneous leishmaniasis with minimal side effects.
McGwire BS, Satoskar AR. Leishmaniasis: clinical syndromes and treatment. QJM. 2014;107(1):7–14. doi: 10.1093/qjmed/hct116.
Geographical distribution of leishmaniasis. Geneva: WHO. Available at: http://www.who.int/emc/diseases/leish/leisgeo.html.
Ghosn, S.H., Kurban, A.K., 2008. Infestations, bites and stings, seventh ed.. In: Wolff, K., Goldsmith, L.A., Katz, S.I., Gilchrest, B.A., Paller, A.S., Leffell, D.J. (Eds.),. In: Fitzpatrick’s Dermatology in General Medicine, 206 McGraw-Hill-Company, New York, pp. 2001–2029.
Griffiths WAD, Croft SL. Cutaneous Leishmaniasis. Postgraduate doctors
Middle East 1980; 3:338-94
Goto H, Lindoso JA. Current diagnosis and treatment of cutaneous and mucocutaneous leishmaniasis. Expert Rev Anti Infect Ther. 2010;8(4):419–433. doi: 10.1586/eri.10.19.
Sharquie, K.E., Al-Talib, K., 1988. Intralesional therapy of cutaneous
leishmaniasis with sodium stibogluconate antimony. Br. J. Dermatol.
Selim, M.M., Vilasin, Z., Jaroskova, L., 1990. Leishmaniasis. In: Currently recommended treatment. Int. J. Dermatol. 29, 318–320.
Aronson NE, Wortmann GW, Byrne WR, Howard RS, Bernstein WB, Marovich MA, et al. A randomized controlled trial of local heat therapy versus intravenous sodium stibogluconate for the treatment of cutaneous Leishmania major infection. PLoS Negl Trop Dis. 2010;4(3):e628. doi: 10.1371/journal.pntd.0000628.
Reithinger R, Mohsen M, Wahid M, Bismullah M, Quinnell RJ, Davies CR, et al. Efficacy of thermotherapy to treat cutaneous leishmaniasis caused by Leishmania tropica in Kabul, Afghanistan: a randomized, controlled trial. Clin Infect Dis. 2005;40(8):1148– 1155. doi: 10.1086/428736
Gurei, M.S., Tatli, N., Ozbilge, H., Erel, O., Seyrek, A., Kocyigit, A., 2000. Efficacy of cryotherapy and intralesional pentostam in treatment of cutaneous leishmaniasis. J. Egypt Soc. Parasitol. 30, 169–176.
Shamsi Meymandi, S., Zandi, S., Aghaie, H., Heshmatkhah, A., 2011. Efficacy of CO2 laser for treatment of anthroponotic cutaneous leishmaniasis, compared with combination of cryotherapy and intralesional meglumine antimoniate. J. Eur. Acad. Dermatol. Venereol. 25 (5), 587–591.
Sharquie, K.E., Hussian, A.K., Turki, K.M., 1994. Intralesional therapy of cutaneous leishmaniasis with Hypertonic Sodium Chloride Solution. J. Pan-Arab Ass. Dermatol. 5, 85–91.
Yasmin, R., Khan, I., Ahmad, S.A., 2011. Response to treatment of cutaneous leishmaniasis with intralesional chloroquine vs intralesional meglumine antimoniate. J. Pak. Assoc. Dermatol. 21 (4), 270–275.
Sharquie, K.E., Najem, R.A., Farjou, I.B., 1997. A comparative control trail of intralesional administrated zinc sulfate, hypertonic saline chloride and pentovalent antimony compound against acute cutaneous leishmaniasis. Clin. Exp. Dermatol. 22, 169–173.
Nameer k. Al-sudany, Yousif J. Ali.Intralesional 8.33% Rifamycin infiltration; New treatment for cutaneous leishmaniasis. Journal of Dermatology & Dermatologic Surgery 20 (2016) 39–45
Asilian, A., Jalayer, T., Nilforooshzadeh, M., Ghassemi, R.L., Peto, R., Wayling, S., 2003. Treatment of cutaneous leishmaniasis with aminosidine (paromomycin) ointment: double-blind, randomized trial in the Islamic Republic of Iran. Bull. World Health Organ. 81, 353–359.
Larbi, E.B., Al_Khawajah, A., Al-Gindan, Y., Jain, S., Abahusain, A., Al-Zayer, A., 1995. A randomized double–blind clinical trial of topical clotrimazole versus miconazole for treatment of cutaneous leishmaniasis in the eastern province of Saudi Arabia. Am. J. Trop. Med. Hyg. 52, 166–168.
Joint Formula Committee. Infections. In: British National Pharmacopoeia. 66thed. London BMJ Group and RPS Publishing. 2014 Mar; 5:338–442.
Salmanpour, R., Handjani, F., Nouhpisheh, M.K., 2001. Comparative study of the efficacy of oral ketoconazole with intra-lesional meglumine antimoniate (Glucantime) for the treatment of cutaneous leishmaniasis. J. Dermatolog. Treat. 12, 159–162.
Momeni, A.Z., Jalayer, T., Emamjomeh, M., Bashardost, N., Ghassemi, R.L., Meghdadi, M., 1996. Treatment of cutaneous leishmaniasis with itraconazole. Randomized double-blind study. Arch. Dermatol. 132, 784–786.
Jaffar, Huma, 2006. Rifampicin in cutaneous leishmaniasis: a therapeutic
trial in Saudi Arabia. J. Pak. Assoc. Dermatol. 16, 4–9.
Silva-Vergara, M.L., Silva, L.A., Maneira, F.R.Z., Silva, A.G., Prata, A., 2004. Case report: azithromycin in the treatment of mucosal leishmaniasis. Rev. Inst. Med. Trop. Sao Paulo 46, 175–177.
Al-Mutaii, N., Alshiltawy, M., El Khalawany, M., Joshi, A., Eassa, B., Manchanda, Y., Gomaa, S., Darwish, I., Rijhwani, M., 2009. Treatment of Old World cutaneous leishmaniasis with dapsone, itraconazole, cryotherapy, and imiquimod, alone and in combination. Int. J. Dermatol. 48, 862–869.
Sharquie, K.E., Najm, R.A., Farjou, I.B., Al-Timimi, D.J., 2001. Oral zinc sulfate in the treatment of acute cutaneous leishmaniasis. Clin. Exp. Dermatol. 26, 21–26.
Khatami, A., Firooz, A., Gorouhi, F., Dowlati, Y., 2007. Treatment of acute old world Cutaneous leishmaniasis. A systemic review of the randomized controlled trials. J. Am. Acad. Dermatol. 57, 1–29.
Sahar H. al-Natour. Update in the treatment of cutaneous leishmaniasis . J. Family Community Med. 2009 May-Aug; 16(2): 41 – 47.
Guderian RH, Chico ME,Rogers MD, Pattishall KM, Grogi M, Berman JD. Placebo controlled treatment of Ecuadorian cutaneous leishmaniasis. Am J Trop Med Hyg 1991;45:92-7.
DanYang, MinglongChen, YingSun, YunpanJin, ChaoLu, XinPan, GuilanQuan, .Microneedle-mediated transdermal drug delivery for treating diverse skin diseases. Acta Biomaterialia. Volume 121, February 2021, Pages 119-133
SVCB Gonçalves, CHN Costa .Treatment of cutaneous leishmaniasis with thermotherapy in Brazil: an efficacy and safety study. Anais Brasileiros de Dermatologia Volume93,Issue 3, May–June 2018, Pages 347-355
Valencia, Braulio M., Miller David; Witzig, Richard S., Boggild Andrea K., Llanos-Cuentas Alejandro. Novel Low-Cost Thermotherapy for Cutaneous Leishmaniasis in Peru. PLoS neglected tropical diseases 7 (5), e2196, 2013